Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
74 participants
OBSERVATIONAL
2015-05-28
2016-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, it is in our opinion that in follow-up, clinical assessment of viscoelastic properties will be useful for monitoring denervated muscle; also treatment programs and purposes for OBPP should be varying according to the muscle properties.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Pain Finding in Infants With Brachial Plexus Birth Injury
NCT06415747
Birth Complications and Intrauterine Constraints in the Etiology of Congenital Muscular Torticollis: A Nationwide Registry Study
NCT06901414
3D Characterisation of the Skull Base Deformation in Congenital Muscular Torticollis
NCT04421898
Non-Anesthetized Plexus Technique for Infant (BPBP) MRI Evaluation
NCT03560999
Surgery or Clincial Follow up, in Patients With Bell' s Palsy
NCT02179684
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1, 0-5 months old
Children which is Obstetric brachial plexus palsy and 0-5 months old age have Naracas type 2 lesion.
No interventions assigned to this group
Group 2, 6-24 months old
Children which is Obstetric brachial plexus palsy and 6-24 months old age have Naracas type 2 lesion.
No interventions assigned to this group
Group 3, 25-36 months old
Children which is Obstetric brachial plexus palsy and 25-36 months old age have Naracas type 2 lesion.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* having low birth weight or premature birth history,
* having a systemic, genetic or neuromuscular disease.
36 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kıvanç Delioğlu
Principal Investigator, MSc
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
kıvançOBPP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.